Login to Your Account



Other News To Note


Wednesday, July 10, 2013
Athersys Inc., of Cleveland, said study results in Stem Cells Translational Medicine demonstrated that Multipotent Adult Progenitor Cells (MAPC) increase the long-term survival of organ transplants in instances when the cell donor is not related to the patient or the organ donor, and also appear to alleviate the need for long-term immune suppression.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription